1634330- PIONEER |
|
Madrid Monitor
International Trademark 
| Trademark | Holder | Registration Date | Expiration Date | Nice classes |
|---|---|---|---|---|
|
PIONEER
|
Bio-Rad Europe GmbH
|
06.10.2021
|
06.10.2031
|
01, 05, 40, 42
|
Printed : 10/03/2011
2026-08-19
732
Name and address of the holder of the registration
Bio-Rad Europe GmbH
Holbeinstrasse 75
CH-4051 Basel
(CH)
812
Contracting State or Contracting Organization in the territory of which the holder has a real and effective industrial or commercial establishment
CH
842
Legal nature of the holder (legal entity) and State, and, where applicable, territory within that State where the legal entity is organized
a limited liability company, Switzerland
Registered with the Commercial Register of Canton Basel-Stadt under registration number CHE-378.386.158
740
Name and address of the representative
Kilpatrick Townsend & Stockton LLP
Two Embarcadero Center, Suite 1900
San Francisco CA 94111
(US)
541
Reproduction of the mark where the mark is represented in standard characters
511
International Classification of Goods and Services for the Purposes of the Registration of Marks (Nice Classification)
-
NCL(11-2021)
- 01
-
Chemicals for use in industry and science; biological preparations for scientific, industrial, and research use; antibodies for research use, other than for medical or veterinary purposes; antibody libraries, for scientific, industrial or research use; libraries of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagents for scientific or research use.
- 05
-
Biological preparations for medical use; pharmaceutical, biopharmaceutical and medical preparations, agents and substances; diagnostic preparations, agents and substances for medical purposes; antibodies for medical purposes; immunoglobulins, antibodies, or fragments thereof, for medical use; antibody libraries, for medical and veterinary use; libraries of immunoglobulins, antibodies, or fragments thereof, for medical use; products containing immunoglobulins, antibodies, or fragments thereof, for use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for clinical or medical laboratory use.
- 40
-
Antibody generation and antibody production for others, antibody purification, antibody fragmentation, and manufacture of antibodies for others; custom production of cell cultures and biological products in the nature of antibodies and proteins and related reagents; custom antibody production; custom manufacturing for others, namely, manufacturing of chemical and biotechnological materials for others, namely, manufacturing of organisms, compounds and materials for use in the pharmaceutical, agrochemical, chemical, biotechnology industries.
- 42
-
Antibody generation services being research and development services; medical and scientific research for the identification, preparation, and development of antibody libraries; laboratory research and analysis services in the nature of preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins; design of antibody libraries for medical or veterinary use; scientific and technological services, namely, scientific and technological research, analysis, inspection, quality audit, consulting, design, engineering, development and laboratory testing services for others; chemical research and development services; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals for use in medicines, reagents for use in medicines, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, protein chemist; industrial analysis and research services; pharmaceutical, medical, scientific and biopharmaceutical research and development; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines.
821
Basic application
EM,
24.09.2021,
018564945
300
Data relating to priority under the Paris Convention and other data relating to registration of the mark in the country of origin
EM, 24.09.2021, 018564945
832
Designation(s) under the Madrid Protocol
AU - CH - GB - JE - JP - US
527
Indications regarding use requirements
GB - JE - US
Transaction History
International Registration, AU, CH, GB, JP, US
: 23.12.2021, 2021/49 Gaz
151
Date of the registration
06.10.2021
450
Publication number and date
2021/49 Gaz,
23.12.2021
832
Designation(s) under the Madrid Protocol
AU - CH - GB - JP - US
527
Indications regarding use requirements
GB - US
581
Date of notification by the International Bureau to the designated Contracting Parties (from which the time limit to notify the refusal starts)
23.12.2021
270
Language of the application
English
![[PDF]](data:image/gif;base64,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)
Partial provisional refusal of protection, AU
: 03.02.2022, 2022/3 Gaz 833
Interested Contracting Party(ies)
AU
450
Publication number and date
2022/3 Gaz,
03.02.2022
862
Partial provisional refusal of protection
580
Date of notification
19.01.2022
Date of receipt by the International Bureau
14.01.2022
Statement of grant of protection made under Rule 18ter(1), GB
: 07.07.2022, 2022/25 Gaz 833
Interested Contracting Party(ies)
GB
450
Publication number and date
2022/25 Gaz,
07.07.2022
Date of receipt by the International Bureau
22.06.2022
Total provisional refusal of protection, US
: 14.07.2022, 2022/26 Gaz 833
Interested Contracting Party(ies)
US
450
Publication number and date
2022/26 Gaz,
14.07.2022
580
Date of notification
28.06.2022
Date of receipt by the International Bureau
25.06.2022
Total provisional refusal of protection, JP
: 03.11.2022, 2022/42 Gaz 833
Interested Contracting Party(ies)
JP
450
Publication number and date
2022/42 Gaz,
03.11.2022
580
Date of notification
24.10.2022
Date of receipt by the International Bureau
20.10.2022
Total provisional refusal of protection, CH
: 01.12.2022, 2022/46 Gaz 833
Interested Contracting Party(ies)
CH
450
Publication number and date
2022/46 Gaz,
01.12.2022
580
Date of notification
21.11.2022
Date of receipt by the International Bureau
17.11.2022
Opposition possible after the 18 months time limit, AU
: 12.01.2023, 2022/52 Gaz
833
Interested Contracting Party(ies)
AU
450
Publication number and date
2022/52 Gaz,
12.01.2023
Ex Officio examination completed but opposition or observations by third parties still possible, under Rule 18bis(1), US
: 19.01.2023, 2023/1 Gaz 833
Interested Contracting Party(ies)
US
450
Publication number and date
2023/1 Gaz,
19.01.2023
Ex Officio examination completed but opposition or observations by third parties still possible, under Rule 18bis(1), AU
: 06.04.2023, 2023/12 Gaz 833
Interested Contracting Party(ies)
AU
450
Publication number and date
2023/12 Gaz,
06.04.2023
Opposition end date
17.03.2023
Confirmation of total provisional refusal under Rule 18ter(3), CH
: 18.05.2023, 2023/18 Gaz 833
Interested Contracting Party(ies)
CH
450
Publication number and date
2023/18 Gaz,
18.05.2023
Statement indicating the goods and services for which protection of the mark is granted under Rule 18ter(2)(ii), AU
: 08.06.2023, 2023/21 Gaz 833
Interested Contracting Party(ies)
AU
450
Publication number and date
2023/21 Gaz,
08.06.2023
Goods and services for which protection of the mark is granted
- 01
-
Antibodies for research use, other than for medical or veterinary purposes; antibody libraries, for scientific, industrial or research use; libraries of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagents for scientific or research use.
- 05
-
Antibodies for medical purposes; immunoglobulins, antibodies, or fragments thereof, for medical use; antibody libraries, for medical and veterinary use; libraries of immunoglobulins, antibodies, or fragments thereof, for medical use; products containing immunoglobulins, antibodies, or fragments thereof, for use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for clinical or medical laboratory use.; Diagnostic preparations for medical purposes.
580
Date of notification
08.06.2023
Date of receipt by the International Bureau
24.05.2023
Statement indicating the goods and services for which protection of the mark is granted under Rule 18ter(2)(ii), US
: 10.08.2023, 2023/30 Gaz 833
Interested Contracting Party(ies)
US
450
Publication number and date
2023/30 Gaz,
10.08.2023
Goods and services for which protection of the mark is granted
- 01
-
Chemicals for use in industry and science, namely, diagnostic kits consisting primarily of antibodies and reagents for use in disease testing; biological preparations in the nature of antibodies for research use, other than for medical or veterinary purposes; antibody libraries, for scientific, industrial or research use, namely, biological preparations in the nature of antibodies sold together; libraries of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use, namely, biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof sold together as a kit; biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof, for scientific, industrial, and research use; assays and reagents for use in genetic research; diagnostic reagents for scientific and research use; reagents and kits comprising chemical reagents, both for scientific or research use in the field of diagnosing diseases.
- 05
-
Biological preparations for the treatment of infectious diseases, deficiency diseases, hereditary diseases, and physiological diseases; pharmaceutical, biopharmaceutical and medical preparations for the treatment of infectious diseases, deficiency diseases, hereditary diseases, and physiological diseases; diagnostic preparations for medical purposes; antibodies for medical purposes; biological preparations, namely, immunoglobulins, antibodies, or fragments thereof, for medical use; antibody libraries, for medical and veterinary use, namely, collections of antibodies for medical purposes; libraries of immunoglobulins, antibodies, or fragments thereof, for medical use, namely, collections of biological preparations in the nature of immunoglobulins, antibodies, or fragments thereof, for medical use, sold as a unit; biological preparations comprised of immunoglobulins, antibodies, or fragments thereof, for use in medicine; diagnostic reagents for medical purposes; diagnostic reagents for medical use; diagnostic reagents for medical clinician or medical use.
- 40
-
Antibody production for others, and manufacture of antibodies for others; custom manufacture of antibodies, namely, antibody purification, antibody fragmentation; custom production of cell cultures and biological products in the nature of antibodies and proteins and related reagents; custom antibody production; custom manufacturing for others, namely, manufacturing of chemical and biotechnological materials for others, namely, manufacturing of organisms, compounds and materials for use in the pharmaceutical, agrochemical, chemical, biotechnology industries.
- 42
-
Research and development in the field of antibody generation services; medical and scientific research for the identification, preparation, and development of antibody libraries; Chemical, biochemical, biological and bacteriological research and analysis services in the nature of preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins; design of antibody libraries for medical or veterinary use; scientific and technological services, namely, scientific and technological research, analysis, inspection, quality audit, consulting, design, engineering, development and laboratory testing services for others; research and development services in the field of developing new chemicals; testing or scientific research on biotechnology and providing scientific information and research consultancy relating thereto; providing information and consultancy on testing, inspection or research of pharmaceuticals, chemicals for use in medicines, reagents for use in medicines, cosmetics or foodstuffs; scientific or laboratory testing, inspection or research of nucleic acids, chemicals and pharmaceuticals for drug development and medical research purposes, and providing scientific information and research consultancy relating thereto; genomic experiments, analyses, research, assays, tests, inspection, detection or verification, namely, scientific laboratory services being scientific genomic analyses, scientific genomic research, custom design and development of biochemical genomic assays, genome amplification and functional and structural analysis of genomes; scientific laboratory services of a chemist, biologist, biochemist, biotechnologists, gene technologists, molecular biologists, pharmacists, protein chemist; chemical and biological analysis and research services; pharmaceutical, medical, scientific and biopharmaceutical research and development; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines.
580
Date of notification
10.08.2023
Date of receipt by the International Bureau
26.07.2023
Confirmation of total provisional refusal under Rule 18ter(3), JP
: 05.10.2023, 2023/38 Gaz 833
Interested Contracting Party(ies)
JP
450
Publication number and date
2023/38 Gaz,
05.10.2023
INITIAL_LINKS
: ..: After correction of ..
1634330
Change of ownership
: 20.05.2022, 2022/20 Gaz
LOADING
International Trademark
Disclaimer: The registration of a mark in the International Register does not imply the expression of any opinion whatsoever on the part of the International Bureau of WIPO concerning the substance of the entitlement claim under the Madrid Protocol and its Regulations, or of the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.